Grail develops the Galleri multi-cancer early detection blood test, mapping tumor genomic signals to intercept cancer early.
Get unlimited access to analyze competitor ads, save creatives, and discover winning strategies.
See all ads on AdLibrary →GRAIL is a healthcare company developing multi-cancer early detection blood tests, including its Galleri test, aimed at screening for multiple cancer types from a single blood draw. It works with health systems and physicians to expand access to early cancer screening. The company positions itself at the forefront of liquid biopsy diagnostics.
